{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:52:02Z","timestamp":1791305522429,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical Research and Development","award":["EBB14004"],"award-info":[{"award-number":["EBB14004"]}]},{"name":"Medical Research and Development","award":["CBA14003"],"award-info":[{"award-number":["CBA14003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbrc.2017.02.039","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T10:32:14Z","timestamp":1486549934000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia\/lymphoma"],"prefix":"10.1016","volume":"485","author":[{"given":"Shunsuke","family":"Shimosaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonaga","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kubuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.02.039_bib1","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2017.02.039_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cas.12617","article-title":"Recent advances in the treatment of adult T-cell leukemia-lymphomas","volume":"106","author":"Utsunomiya","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2017.02.039_bib3","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.02.039_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.02.039_bib5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","article-title":"A\u00a0neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients","volume":"103","author":"Moura","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.02.039_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10549-009-0345-x","article-title":"Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen","volume":"119","author":"Habashy","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2017.02.039_bib7","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ejca.2004.01.036","article-title":"Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas","volume":"40","author":"Ryschich","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2017.02.039_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5603\/FHC.2012.0040","article-title":"Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia","volume":"50","author":"P\u0142oszy\u0144ska","year":"2012","journal-title":"Folia Histochem Cytobiol."},{"key":"10.1016\/j.bbrc.2017.02.039_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/X8LBRRBBC43PL9HC","article-title":"The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas","volume":"126","author":"Wu","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbrc.2017.02.039_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbrc.2017.02.039_bib11","first-page":"1259","article-title":"Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42\/6","volume":"1","author":"Brooks","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2017.02.039_bib12","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1158\/0008-5472.CAN-10-0938","article-title":"Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas","volume":"70","author":"Cr\u00e9pin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.02.039_bib13","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1073\/pnas.0712202105","article-title":"Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic","volume":"105","author":"Kurosawa","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2017.02.039_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbrc.2008.11.129","article-title":"Isolation of antigen\/antibody complexes through organic solvent (ICOS) method","volume":"378","author":"Akahori","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.02.039_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/cam4.267","article-title":"Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer","volume":"3","author":"Nagai","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2017.02.039_bib16","first-page":"1238","article-title":"Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma","volume":"26","author":"Nakahata","year":"2012","journal-title":"Leuk. 2012"},{"key":"10.1016\/j.bbrc.2017.02.039_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2017.02.039_bib18","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","article-title":"Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.02.039_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights","volume":"368","author":"Manz","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2017.02.039_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2008.02.038","article-title":"Redox signaling and cancer: the role of \"labile\" iron","volume":"266","author":"Galaris","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2017.02.039_bib21","doi-asserted-by":"crossref","first-page":"16430","DOI":"10.1074\/jbc.M113.541490","article-title":"HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism","volume":"289","author":"Moroishi","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.02.039_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","article-title":"The transferrin receptor and the targeted delivery of therapeutic agents against cancer","volume":"1820","author":"Daniels","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.02.039_bib23","first-page":"6295","article-title":"Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in\u00a0vitro and in\u00a0vivo: evidence for synergistic antiproliferative effects","volume":"50","author":"White","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.02.039_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/jnci\/86.6.450","article-title":"Effects of combined antigrowth factor receptor treatment on in\u00a0vitro growth of multiple myeloma","volume":"86","author":"Taetle","year":"1994","journal-title":"J.\u00a0Natl. Cancer Inst."}],"updated-by":[{"DOI":"10.1016\/j.bbrc.2020.05.147","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000}}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17303078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17303078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:13:17Z","timestamp":1757761997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17303078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0006291X17303078"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.039","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bbrc.2020.05.147","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}